Clover Ebitda from 2010 to 2024

CLOV Stock  USD 3.37  0.01  0.30%   
Clover Health EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA will likely drop to about -221.4 M in 2024. During the period from 2010 to 2024, Clover Health EBITDA regression line of quarterly data had r-squared of  0.13 and coefficient of variation of (50.91). View All Fundamentals
 
EBITDA  
First Reported
2019-12-31
Previous Quarter
M
Current Value
-8.4 M
Quarterly Volatility
60.7 M
 
Covid
Check Clover Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clover Health's main balance sheet or income statement drivers, such as Interest Expense of 6.7 K, Other Operating Expenses of 1.8 B or Minority Interest of 3.1 M, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.0 or PTB Ratio of 1.68. Clover financial statements analysis is a perfect complement when working with Clover Health Valuation or Volatility modules.
  
Check out the analysis of Clover Health Correlation against competitors.

Latest Clover Health's Ebitda Growth Pattern

Below is the plot of the Ebitda of Clover Health Investments over the last few years. It is Clover Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clover Health's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Clover Ebitda Regression Statistics

Arithmetic Mean(216,270,550)
Coefficient Of Variation(50.91)
Mean Deviation63,892,347
Median(182,648,000)
Standard Deviation110,097,184
Sample Variance12121.4T
Range490.9M
R-Value(0.36)
Mean Square Error11407.1T
R-Squared0.13
Significance0.19
Slope(8,743,760)
Total Sum of Squares169699.5T

Clover Ebitda History

2024-221.4 M
2023-210.8 M
2022-337 M
2021-569.6 M
2020-78.7 M

About Clover Health Financial Statements

Clover Health investors use historical fundamental indicators, such as Clover Health's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Clover Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-210.8 M-221.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clover Stock Analysis

When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.